Antipsychotic News and Research

RSS

Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.

Risperidone may help people with autism

Risperidone, a drug used to control schizophrenia symptoms, may also help treat behaviors found in autism spectrum disorder, according to a new review of studies.

30 Jan 2007

Older schizophrenia drugs cheaper and work just as well

According to a new study an older antipsychotic drug has been found to be both cheaper and as effective for some patients with schizophrenia as the newer drugs on the market.

4 Dec 2006

Schizophrenia treatment with older, generic antipsychotics cheaper, as effective as treatment with newer drugs

Treating schizophrenia patients with older, less expensive antipsychotic drugs reduces overall treatment costs by up to 30% and produces no increase in side effects or decrease in effectiveness compared with newer, brand-name medications.

2 Dec 2006

Symptoms of schizophrenia eased by music therapy

According to British researchers, some of the symptoms of schizophrenia may be eased with music therapy.

1 Nov 2006

Experts say "schizophrenia label" a harmful concept which should be dropped

British mental health experts say the term schizophrenia should abandoned as it has little scientific validity, and is imprecise and stigmatizing.

From The University of Manchester 10 Oct 2006

Schizophrenia drug to be used to treat autism

A drug normally used to treat schizophrenia has been given approval by the U.S. the Food and Drug Administration for use in treating the symptoms of autism in children and adolescents.

9 Oct 2006

FDA approves Risperdal to treat irritability associated with autism

The U.S. Food and Drug Administration (FDA) has approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.

8 Oct 2006

Study compares delivery methods of schizophrenia medicines

More than half of schizophrenia patients don't take their medication as directed and a new study will determine whether biweekly physician visits and injectable drugs can change that.

12 Sep 2006

High rates of off-label prescriptions for antidepressant, anticonvulsant and antipsychotic drugs

A University of Georgia study has found that three-quarters of people prescribed antidepressant drugs receive the medications for a reason not approved by the federal Food and Drug Administration.

26 Jul 2006

Little evidence that wandering prevention works in dementia

Everything from multicolored lights to garden walks has been suggested as ways to keep people with dementia from wandering, but there is little evidence to show that any of these interventions work, according to a new analysis.

19 Jul 2006

Clozapine has serious health consequences

Patients who take clozapine, the most effective antipsychotic drug, have significantly higher rates of metabolic syndrome, according to a first-of-a-kind study by University of Rochester Medical Center researchers.

3 Jul 2006

Antipsychotic use in children increasing

A steadily increasing number of patients younger than age 20 received prescriptions for antipsychotic medications between 1993 and 2002, according to a report published in the June issue of Archives of General Psychiatry.

9 Jun 2006

Olanzapine appears to lower or delay full-blown psychosis

For young people who clearly seem to be developing early signs of schizophrenia, treatment with the antipsychotic drug olanzapine appears to lower or delay the rate of conversion to full-blown psychosis, according to an article by a Yale School of Medicine researcher in the May issue of The American Journal of Psychiatry.

3 May 2006

Study shows drugs work differently in the brains of men and women

A Johns Hopkins discovery could lead to tailored treatments for drug abuse and neurological diseases after providing what is believed to be the first evidence in people that amphetamines have a greater effect on men's brains than women's.

24 Apr 2006

Study finds nationwide increase in antipsychotic medications used for children with ADHD

A disturbing nationwide trend has been documented by a researcher at the Monroe Carell Jr. Children's Hospital at Vanderbilt: Doctors are prescribing antipsychotic medicines for children with behavioral problems that are not defined as "psychosis," such as attention deficit hyperactivity disorder (ADHD).

18 Apr 2006

No evidence that early episodes of schizophrenia without medication result in long-term harm

A University of Southern California - USC review of published research has found no evidence that early episodes of schizophrenia without medication result in long-term harm for patients, casting doubt on the practice to immediately medicate for a year.

28 Mar 2006

No evidence that early episodes of schizophrenia without medication result in long-term harm

A USC review of published research has found no evidence that early episodes of schizophrenia without medication result in long-term harm for patients, casting doubt on the practice to immediately medicate for a year.

23 Mar 2006

Researchers create animal model of any schizophrenic characteristics

Researchers have developed a mouse strain in which the abnormal activity of the dopamine machinery in a specific part of the brain causes cognitive and behavioral impairments mimicking those in human schizophrenics.

20 Feb 2006

Elderly as much at risk with old mental health drugs as new ones

Researchers at the Brigham and Women's Hospital in Boston are saying that many of the older drugs designed to treat mental problems such as delirium, agitation and psychosis may be even more hazardous to the elderly than newer medicines that now carry U.S. government warnings.

2 Dec 2005

LGC licenses first DNA test for response to schizophrenia treatment from the Institute of Psychiatry, King’s College London

LGC, Europe's leading independent analytical laboratory providing advanced chemical, biochemical and forensic analysis, has announced an exclusive agreement with King’s College London to offer the first pharmacogenetic screening service which will predict whether a patient with schizophrenia will respond positively to the antipsychotic drug clozapine.

8 Nov 2005